학술논문
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial
Document Type
Article
Author
Source
In: The Lancet Psychiatry . (The Lancet Psychiatry, August 2017, 4(8):595-604)
Subject
Language
English
ISSN
22150374
22150366
22150366